Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 +0.28 (+3.35%)
As of: Nov 11, 2026 · 3:59 PM EST

Aspire-Lakewood Holdings (ASBP) Revenue (2025 - 2026)

Updated

Aspire Biopharma Holdings' Revenue was $63,104 in Q2 2026, up 122.6% from the prior quarter.

Analysis

Aspire-Lakewood Holdings (ASBP) Revenue (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aspire Biopharma Holdings' Revenue was $97,659 through Jun 30, 2026; for FY2025, it was $6,202.

  • Per Business Quant data, ASBP's Revenue in the three quarters before Q2 2026 was $28,353 (Q1 2026), $4,261 (Q4 2025) and $1,941 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Aspire-Lakewood Holdings 63.98 Mn 43.01 Mn -30,086.00 63,104.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63,104.00
Mar 31, 2026 28,353.00
Dec 31, 2025 4,261.00
Sep 30, 2025 1,941.00
API Access

Aspire-Lakewood Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ASBP&period=max&api_key=YOUR_API_KEY